Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Dyne Therapeutics Inc
(NQ:
DYN
)
25.95
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, May 9, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Dyne Therapeutics Inc
< Previous
1
2
3
4
Next >
Dyne Therapeutics to Present New Preclinical Data at ASGCT Annual Meeting Demonstrating FORCE™ Platform Delivery to CNS
May 02, 2023
From
Dyne Therapeutics, Inc.
Via
GlobeNewswire
Acuity Brands, C3.ai And Other Big Stocks Moving Lower On Tuesday
April 04, 2023
U.S. stocks traded lower, with the Dow Jones dropping more than 100 points on Tuesday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Dyne Therapeutics Receives FDA Orphan Drug and Rare Pediatric Designations for DYNE-251 for the Treatment of Duchenne Muscular Dystrophy
March 23, 2023
From
Dyne Therapeutics, Inc.
Via
GlobeNewswire
Dyne Therapeutics Announces Presentations on its DM1 and DMD Programs at the 2023 Muscular Dystrophy Association Clinical & Scientific Conference
March 20, 2023
From
Dyne Therapeutics, Inc.
Via
GlobeNewswire
What 4 Analyst Ratings Have To Say About Dyne Therapeutics
March 03, 2023
Via
Benzinga
Chardan Initiates Coverage On These 'Intriguing Small-Cap Stories"
July 20, 2022
Via
Benzinga
Dyne Therapeutics to Present at Upcoming Investor Conferences
March 07, 2023
From
Dyne Therapeutics, Inc.
Via
GlobeNewswire
Dyne Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Business Highlights
March 02, 2023
From
Dyne Therapeutics, Inc.
Via
GlobeNewswire
Analyst Says This Small Cap Biotech Firm Has 'Very Valuable Therapeutic,' Upgrades Stock
February 27, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 27, 2023
February 27, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 15, 2023
February 15, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
February 07, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 26, 2023
January 26, 2023
Via
Benzinga
Dyne Therapeutics to Present at 41st Annual J.P. Morgan Healthcare Conference
January 03, 2023
From
Dyne Therapeutics, Inc.
Via
GlobeNewswire
$10 Million Bet On Dyne Therapeutics? Check Out These 4 Stocks Insiders Are Buying
December 15, 2022
Although US stocks closed lower on Wednesday following Fed’s rate decision, there were a few notable insider trades.
Via
Benzinga
Why Netcapital Shares Are Trading Lower By Over 33%? Here Are 50 Stocks Moving In Wednesday's Mid-Day Session
December 14, 2022
Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares rose 153% to $0.3325 after gaining 14% on Tuesday. Crown ElectroKinetics, last month, posted a Q3 loss of $0.18 per share.
Via
Benzinga
REV Group, Avidity Biosciences And Some Other Big Stocks Moving Higher On Wednesday
December 14, 2022
U.S. stocks traded higher, with the Dow Jones gaining over 100 points on Wednesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Why American Eagle Outfitters Shares Climbed Over 18%; Here Are 78 Biggest Movers From Yesterday
November 23, 2022
Gainers Cosmos Holdings Inc. (NASDAQ: COSM) jumped 86.9% to close at $0.3275 on Tuesday after jumping 21% on Monday. Cosmos Health agreed to sell its Sky Premium Life Luxury food supplement brand on...
Via
Benzinga
Dyne Therapeutics: Q3 Earnings Insights
November 03, 2022
Dyne Therapeutics (NASDAQ:DYN) reported its Q3 earnings results on Thursday, November 3, 2022 at 07:28 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Dyne Therapeutics Reports Third Quarter 2022 Financial Results and Business Highlights
November 03, 2022
From
Dyne Therapeutics, Inc.
Via
GlobeNewswire
Dyne Therapeutics to Present at Investor Conferences in November
November 02, 2022
From
Dyne Therapeutics, Inc.
Via
GlobeNewswire
Dyne Therapeutics Receives FDA Fast Track Designation for DYNE-251 for the Treatment of Duchenne Muscular Dystrophy
October 31, 2022
From
Dyne Therapeutics, Inc.
Via
GlobeNewswire
Dyne Therapeutics Presents Preclinical Data from its Duchenne Muscular Dystrophy Programs Targeting Exons 51 and 53 at World Muscle Society 2022 Congress
October 11, 2022
From
Dyne Therapeutics, Inc.
Via
GlobeNewswire
Avidity Biosciences, Kronos Worldwide And Some Other Big Stocks Moving Lower On Tuesday
September 27, 2022
U.S. stocks traded lower, with the Dow Jones dropping around 180 points on Tuesday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Dyne Therapeutics: Q2 Earnings Insights
August 04, 2022
Dyne Therapeutics (NASDAQ:DYN) reported its Q2 earnings results on Thursday, August 4, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Avidity Biosciences Or Dyne Therapeutics - Read On Raymond James' Rating Skew
July 12, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 20, 2022
July 20, 2022
Upgrades
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 12, 2022
July 12, 2022
Upgrades
Via
Benzinga
Alphabet, Dyne Therapeutics And 74 Biggest Movers From Yesterday
July 06, 2022
Gainers Enjoy Technology, Inc. (NASDAQ: ENJY) shares jumped 81.5% to close at $0.31 on Tuesday.
Via
Benzinga
Tesla, Ra Medical Systems And 51 Stocks Moving In Tuesday's Mid-Day Session
July 05, 2022
Gainers Ra Medical Systems, Inc. (NASDAQ: RMED) shares jumped 69.6% to $0.5240 after the company announced it has received FDA 510(k) clearance for its DABRA 2.0 catheter.
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.